サマリー

脊椎インプラントの世界市場は、2023年の112億米ドルから2028年には143億米ドルに達し、予測期間中のCAGRは5.0%で成長すると予測されている。脊椎インプラント市場の急成長が予測される背景には、魅力的な利点が数多くある。特に、脊椎インプラントは、人口の高齢化、脊椎疾患の症例の増加、脊椎手術技術の進歩のための公的/民間組織による研究・資金提供イニシアチブの増加によって牽引されている。さらに、早期診断と早期治療の有効性が向上したことで、脊椎疾患の早期発見が増加しており、脊椎インプラントが最前線のソリューションとして位置づけられる先進的な治療方法に対する需要が高まっている。これらの要因により、市場は堅調な拡大局面を迎えることになり、その結果、今後予測される数年間における脊椎インプラントの採用状況が形成されることになる。

「開腹手術分野が2022-2028年に最大市場シェアを記録"
手術の種類に基づき、脊椎インプラント市場は開放手術と低侵襲手術に区分される。開放手術セグメントは、2022-2028年の予測期間において最大の市場シェアを記録した。このセグメントの成長は、重度の脊柱側弯症や進行した後弯症のような複雑な脊柱変形を伴う症例によるもので、開腹手術が頻繁に好まれる。開腹手術特有の直接的な可視化により、外科医は複雑な解剖学的異常に効果的に対処する能力を高めることができる。さらに、外科医が開腹手技に慣れ親しんでいることや専門知識が、手技の選択に影響することもある。場合によっては、特に伝統的な術式に習熟した外科医にとっては、開腹手術が好まれることもあり、この分野の進歩にさらに拍車をかけている。

「2022年の脊椎インプラント市場は、病院分野がエンドユーザー別で最大のシェアを占めた。
エンドユーザーに基づき、脊椎インプラント市場は病院と整形外科センターに区分される。2022年には、病院セグメントが世界の脊椎インプラント市場で最大のシェアを占めた。このセグメントの成長は、日常的な処置から複雑な介入に至るまで脊椎手術の大部分を占めること、高度な脊椎インプラント技術を早期に採用すること、臨床実践を通じてトレンドを形成することなどの要因によって推進されている。

"アジア太平洋地域は予測期間中に市場の著しい成長率を記録する"
予測期間2023～2028年において、APAC地域は予測期間中に市場で著しい成長率を記録すると予想される。アジア太平洋地域は、インド、中国、日本、オーストラリア、韓国、RoAPACで構成される。アジア太平洋(APAC)地域は、脊椎インプラントの市場成長率の著しい上昇を目撃している。この成長にはいくつかの原動力がある：
アジア太平洋市場は、医療インフラの強化を目的とした新興国の政府機関による投資の増加により成長を遂げている。さらに、独立系整形外科センターの増加、患者数の増加、アジア太平洋地域で脊椎インプラント製品の提供を拡大する業界各社の戦略的イニシアティブも、市場の利益となっている。

本レポートで参照した主な参入企業の内訳は以下の通りである：
- 企業タイプ別ティア1～45%、ティア2～34%、ティア3～21
- 役職別Cレベル-47％、ディレクターレベル-33％、その他-20
- 地域別北米-35%、欧州-32%、アジア太平洋地域-25%、中南米-6%、中東・アフリカ-2

同市場における有力企業は、メドトロニック（アイルランド）、ジョンソン・エンド・ジョンソン-デピュー・シンセズ（米国）、ストライカー・コーポレーション（米国）、ニューベイシブ（米国）などである。

調査範囲

- 本レポートでは、製品、手術の種類、用途、エンドユーザー、地域に基づいて脊椎インプラント市場を調査しています。
- 市場成長に影響を与える要因（促進要因、阻害要因、機会、課題など）を分析しています。
- 利害関係者向けに市場の機会と課題を評価し、市場リーダー向けに競争状況の詳細を提供しています。
- 当レポートでは、脊髄インプラントの世界市場における成長動向、展望、貢献に関してミクロ市場を調査しています。
- 主要5地域に関して市場セグメントの収益を予測しています。

レポート購入の主な利点

本レポートは、包括的なデータの徹底的な分析を通じて、脊椎インプラント市場における新規参入企業/市場リーダー/中小企業の投資評価の実行可能性を支援し、それによって強固なリスク評価を促進し、十分な情報に基づいた投資決定を可能にします。用途、エンドユーザー、地域の次元を包含する綿密な市場セグメンテーションにより、正確なセグメントターゲティングのためのテーラーメイドの洞察が得られます。また、極めて重要なトレンド、課題、成長触媒、将来性などを網羅的に評価し、鋭い洞察力で戦略的意思決定を後押しします。
本レポートでは、以下のポイントに関する洞察を提供しています：
- 脊椎インプラント市場の成長に影響を与える主な促進要因（脊椎疾患有病率の増加、世界的な高齢者人口の増加、脊椎手術技術の継続的進歩）、阻害要因（治療処置の高額費用、償還構造の不確実性）、機会（病院数および手術センター数の増加、新興市場は高成長の機会を提供）、課題（適切な医師の不足、限られた認識）の分析
- 製品開発/イノベーション：脊椎インプラント市場における今後の技術、研究開発活動、新製品・サービスの発売に関する詳細な洞察。
- 市場開発：有利な市場に関する包括的情報 - 当レポートでは、様々な地域の脊椎インプラント市場を分析しています。
- 市場の多様化：脊髄インプラント市場における新製品、未開拓地域、最近の開発、投資に関する詳細な情報
- 競合評価：メドトロニック社（アイルランド）、ジョンソン・エンド・ジョンソン社-デピューシンセ社（米国）、ストライカー社（米国）、ニューベイシブ社（米国）などの主要企業の市場シェア、成長戦略、サービス内容を詳細に評価。

ページTOPに戻る

目次

1 INTRODUCTION 45
1.1 STUDY OBJECTIVES 45
1.2 MARKET DEFINITION 45
1.2.1 INCLUSIONS AND EXCLUSIONS 45
1.3 MARKET SCOPE 46
1.3.1 MARKETS COVERED 46
1.3.2 REGIONS COVERED 46
1.3.3 YEARS CONSIDERED 47
1.4 CURRENCY CONSIDERED 47
1.5 MARKET STAKEHOLDERS 47
1.6 SUMMARY OF CHANGES 48
1.6.1 RECESSION IMPACT 48
2 RESEARCH METHODOLOGY 49
2.1 RESEARCH DATA 49
2.2 RESEARCH DESIGN 50
2.2.1 SECONDARY RESEARCH 50
2.2.1.1 Key data from secondary sources 52
2.2.2 PRIMARY RESEARCH 52
2.2.2.1 Primary sources 52
2.2.2.2 Key industry insights 53
2.2.2.3 Breakdown of primaries 53
FIGURE 1 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY AND DEMAND-SIDE PARTICIPANTS 53
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 54
2.3 MARKET SIZE ESTIMATION 54
FIGURE 3 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 55
2.3.1 BOTTOM-UP APPROACH 55
2.3.1.1 Approach 1: Company revenue estimation approach 56
FIGURE 4 SPINAL IMPLANTS MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ESTIMATION) 56
2.3.1.2 Approach 2: Customer-based market estimation 56
FIGURE 5 SPINAL IMPLANTS MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH 57
2.3.1.3 Approach 3: Top-down approach 57
2.3.1.4 Approach 4: Primary interviews 57
FIGURE 6 TOP-DOWN APPROACH 57
2.4 DATA TRIANGULATION AND MARKET BREAKDOWN 59
FIGURE 7 DATA TRIANGULATION METHODOLOGY 59
2.5 MARKET SHARE ASSESSMENT 60
2.6 STUDY ASSUMPTIONS 60
2.7 RISK ASSESSMENT 60
TABLE 1 ASSOCIATED RISKS 60
2.8 RESEARCH LIMITATIONS 60
2.9 GROWTH RATE ASSUMPTIONS 61
2.10 RECESSION IMPACT 61
3 EXECUTIVE SUMMARY 62
FIGURE 8 SPINAL IMPLANTS MARKET, BY TYPE OF SURGERY, 2023 VS. 2028 (USD MILLION) 62
FIGURE 9 SPINAL IMPLANTS MARKET, BY PRODUCT, 2023 VS. 2028 (USD MILLION) 63
FIGURE 10 SPINAL IMPLANTS MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION) 63
FIGURE 11 SPINAL IMPLANTS MARKET, BY END USER, 2023 VS. 2028 (USD MILLION) 64
FIGURE 12 SPINAL IMPLANTS MARKET: GEOGRAPHICAL SNAPSHOT 65
4 PREMIUM INSIGHTS 66
4.1 SPINAL IMPLANTS MARKET OVERVIEW 66
FIGURE 13 INCREASING INCIDENCE OF SPINAL DISORDERS TO DRIVE MARKET 66
4.2 SPINAL IMPLANTS MARKET: REGIONAL LANDSCAPE, 2023 VS. 2028 (USD MILLION) 66
FIGURE 14 NORTH AMERICA TO RETAIN LARGEST MARKET SHARE 66
4.3 NORTH AMERICA: SPINAL IMPLANTS MARKET, BY COUNTRY AND END USER, 2022 (USD MILLION) 67
FIGURE 15 US AND HOSPITALS HELD LARGEST MARKET SHARES IN 2022 67
4.4 SPINAL IMPLANTS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 67
FIGURE 16 CHINA TO REGISTER HIGHEST CAGR OVER FORECAST PERIOD 67
5 MARKET OVERVIEW 68
5.1 INTRODUCTION 68
FIGURE 17 SPINAL IMPLANTS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 68
5.1.1 DRIVERS 69
5.1.1.1 Innovation in spine surgery technologies 69
5.1.1.2 Increasing incidence of spinal disorders 69
5.1.1.3 Launch of advanced bone graft products 70
5.1.1.4 Increasing demand for MIS procedures 70
5.1.1.5 Growing funding and support for research 71
TABLE 2 RECENT FUNDING FOR R&D IN SPINAL IMPLANTS 71
5.1.2 RESTRAINTS 71
5.1.2.1 High procedural costs 71
5.1.2.2 Unfavorable regulatory processes and limited reimbursement 72
5.1.3 OPPORTUNITIES 72
5.1.3.1 Rising number of hospitals and surgical centers 72
5.1.3.2 Emerging markets 72
5.1.4 CHALLENGES 73
5.1.4.1 Lack of personnel and limited awareness & education for MIS 73
5.2 PORTER’S FIVE FORCES ANALYSIS 73
TABLE 3 SPINAL IMPLANTS MARKET: PORTER’S FIVE FORCES ANALYSIS 73
5.2.1 THREAT OF NEW ENTRANTS 73
5.2.2 THREAT OF SUBSTITUTES 74
5.2.3 BARGAINING POWER OF SUPPLIERS 74
5.2.4 BARGAINING POWER OF BUYERS 74
5.2.5 INTENSITY OF COMPETITIVE RIVALRY 74
5.3 REGULATORY ANALYSIS 74
5.3.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 74
TABLE 4 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 74
TABLE 5 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 75
TABLE 6 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 75
TABLE 7 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 76
TABLE 8 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 76
5.3.1.1 Key regulatory guidelines 76
5.3.1.1.1 US 76
TABLE 9 US FDA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 77
5.3.1.1.2 Europe 78
5.3.1.1.3 Japan 79
5.4 REIMBURSEMENT SCENARIO 79
TABLE 10 REIMBURSEMENT CODES FOR VARIOUS PROCEDURES 79
5.5 ECOSYSTEM/MARKET MAP 81
5.6 VALUE CHAIN ANALYSIS 81
5.6.1 RESEARCH & DEVELOPMENT 81
5.6.2 PROCUREMENT AND PRODUCT DEVELOPMENT 81
5.6.3 MARKETING, SALES AND DISTRIBUTION, AND POST-SALES SERVICES 82
FIGURE 18 SPINAL IMPLANTS MARKET: VALUE CHAIN ANALYSIS 82
5.7 SUPPLY CHAIN ANALYSIS 82
5.7.1 PROMINENT COMPANIES 82
5.7.2 SMALL & MEDIUM-SIZED COMPANIES 82
5.7.3 END USERS 83
FIGURE 19 SPINAL IMPLANTS MARKET: SUPPLY CHAIN ANALYSIS 83
5.8 PRICING ANALYSIS 83
FIGURE 20 AVERAGE SELLING PRICE OF SPINAL IMPLANTS, BY PRODUCT (FY 2021-2023) 83
FIGURE 21 AVERAGE SELLING PRICE TREND OF SPINAL IMPLANTS (2021-2023), BY REGION (USD) 84
5.9 PATENT ANALYSIS 85
FIGURE 22 PATENT DETAILS FOR SPINAL IMPLANTS (JANUARY 2013–DECEMBER 2023) 85
5.10 TRADE ANALYSIS 86
TABLE 11 IMPORT DATA FOR SPINAL IMPLANTS (HS CODE 9021), BY COUNTRY, 2018–2022 (USD THOUSAND) 86
TABLE 12 EXPORT DATA FOR SPINAL IMPLANTS (HS CODE 3822), BY COUNTRY, 2018–2022 (USD THOUSAND) 86
5.11 KEY CONFERENCES AND EVENTS, 2023–2024 87
TABLE 13 SPINAL IMPLANTS MARKET: DETAILED LIST OF KEY CONFERENCES AND EVENTS IN 2023–2024 87
5.12 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 88
FIGURE 23 EMERGING TRENDS AND OPPORTUNITIES AFFECTING FUTURE REVENUE MIX 88
5.13 KEY STAKEHOLDERS AND BUYING CRITERIA 88
5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS 88
TABLE 14 KEY REQUIREMENTS OF STAKEHOLDERS WHILE BUYING SPINAL IMPLANTS (%) 88
5.13.2 KEY STAKEHOLDERS BUYING CRITERIA 89
FIGURE 24 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF SPINAL IMPLANTS 89
TABLE 15 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR KEY PRODUCT SEGMENTS (%) 89
5.14 SPINAL IMPLANTS MARKET: RECESSION IMPACT 89
5.15 UNMET NEEDS AND KEY PAIN POINTS 90
TABLE 16 SPINAL IMPLANTS MARKET: UNMET CUSTOMER NEEDS AND KEY PAIN POINTS 90
6 SPINAL IMPLANTS MARKET, BY PRODUCT 91
6.1 INTRODUCTION 92
TABLE 17 SPINAL IMPLANTS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 92
6.2 THORACIC & LUMBAR FUSION DEVICES 92
TABLE 18 THORACIC & LUMBAR FUSION DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 93
TABLE 19 THORACIC & LUMBAR FUSION DEVICES MARKET, BY REGION, 2021–2028 (USD MILLION) 93
6.2.1 THORACIC & LUMBAR FUSION DEVICES MARKET, BY APPLICATION 94
TABLE 20 THORACIC & LUMBAR FUSION DEVICES MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 94
6.2.2 THORACIC & LUMBAR FUSION DEVICES MARKET, BY TYPE OF SURGERY 94
TABLE 21 THORACIC & LUMBAR FUSION DEVICES MARKET, BY TYPE OF SURGERY, 2021–2028 (USD MILLION) 94
6.2.3 POSTERIOR THORACIC & LUMBAR FUSION DEVICES 94
6.2.3.1 Posterior fusion devices to account for largest market share 94
TABLE 22 POSTERIOR THORACIC & LUMBAR FUSION DEVICES MARKET, BY REGION, 2021–2028 (USD MILLION) 95
6.2.4 INTERBODY THORACIC & LUMBAR FUSION DEVICES 95
TABLE 23 INTERBODY THORACIC & LUMBAR FUSION DEVICES MARKET, BY REGION, 2021–2028 (USD MILLION) 96
6.2.4.1 Interbody thoracic & lumbar fusion devices market, by approach 96
TABLE 24 INTERBODY THORACIC & LUMBAR FUSION DEVICES MARKET, BY APPROACH, 2021–2028 (USD MILLION) 96
6.2.4.1.1 Anterior lumbar interbody fusion devices 97
TABLE 25 ANTERIOR LUMBAR INTERBODY FUSION DEVICES MARKET, BY REGION, 2021–2028 (USD MILLION) 97
6.2.4.1.2 Posterior lumbar interbody fusion devices 97
TABLE 26 POSTERIOR LUMBAR INTERBODY FUSION DEVICES MARKET, BY REGION, 2021–2028 (USD MILLION) 98
6.2.4.1.3 Transforaminal lumbar interbody fusion devices 98
TABLE 27 TRANSFORAMINAL LUMBAR INTERBODY FUSION DEVICES MARKET, BY REGION, 2021–2028 (USD MILLION) 99
6.2.4.1.4 Axial lumbar interbody fusion devices 99
TABLE 28 AXIAL LUMBAR INTERBODY FUSION DEVICES MARKET, BY REGION, 2021–2028 (USD MILLION) 100
6.2.4.2 Interbody thoracic & lumbar fusion devices market, by material 100
TABLE 29 INTERBODY THORACIC & LUMBAR FUSION DEVICES MARKET, BY MATERIAL, 2021–2028 (USD MILLION) 100
6.2.4.2.1 Non-bone interbody fusion devices 100
TABLE 30 NON-BONE INTERBODY FUSION DEVICES MARKET, BY REGION, 2021–2028 (USD MILLION) 101
6.2.4.2.2 Bone interbody fusion devices 101
TABLE 31 BONE INTERBODY FUSION DEVICES MARKET, BY REGION, 2021–2028 (USD MILLION) 101
6.2.5 ANTERIOR THORACIC & LUMBAR FUSION DEVICES 102
6.2.5.1 Minimized impact, low chance of blood loss and infection to support demand 102
TABLE 32 ANTERIOR THORACIC & LUMBAR FUSION DEVICES MARKET, BY REGION, 2021–2028 (USD MILLION) 102
6.3 CERVICAL FUSION DEVICES 103
TABLE 33 CERVICAL FUSION DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 103
TABLE 34 CERVICAL FUSION DEVICES MARKET, BY REGION, 2021–2028 (USD MILLION) 103
6.3.1 CERVICAL FUSION DEVICES MARKET, BY APPLICATION 104
TABLE 35 CERVICAL FUSION DEVICES MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 104
6.3.2 CERVICAL FUSION DEVICES MARKET, BY TYPE OF SURGERY 104
TABLE 36 CERVICAL FUSION DEVICES MARKET, BY TYPE OF SURGERY, 2021–2028 (USD MILLION) 104
6.3.3 ANTERIOR CERVICAL FUSION DEVICES 104
TABLE 37 ANTERIOR CERVICAL FUSION DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 105
TABLE 38 ANTERIOR CERVICAL FUSION DEVICES MARKET, BY REGION, 2021–2028 (USD MILLION) 105
6.3.3.1 Anterior cervical plates 105
6.3.3.1.1 Anterior cervical plates to hold largest share of cervical fusion devices market 105
TABLE 39 ANTERIOR CERVICAL PLATES MARKET, BY REGION, 2021–2028 (USD MILLION) 106
6.3.3.2 Anterior cervical screw systems 106
6.3.3.2.1 Potential risk of injury to limit acceptance 106
TABLE 40 ANTERIOR CERVICAL SCREW SYSTEMS MARKET, BY REGION, 2021–2028 (USD MILLION) 107
6.3.3.3 Cervical interbody fusion devices 107
6.3.3.3.1 Growing use of PEEK over titanium-based devices to support market growth 107
TABLE 41 CERVICAL INTERBODY FUSION DEVICES MARKET, BY REGION, 2021–2028 (USD MILLION) 107
6.3.4 POSTERIOR CERVICAL FUSION DEVICES 108
TABLE 42 POSTERIOR CERVICAL FUSION DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 108
TABLE 43 POSTERIOR CERVICAL FUSION DEVICES MARKET, BY REGION, 2021–2028 (USD MILLION) 108
6.3.4.1 Posterior cervical plates 109
6.3.4.1.1 Plates to hold largest share of posterior cervical fusion devices 109
TABLE 44 POSTERIOR CERVICAL PLATES MARKET, BY REGION, 2021–2028 (USD MILLION) 109
6.3.4.2 Posterior cervical screws 109
6.3.4.2.1 Growing preference for screws over plates in some procedures to favor market growth 109
TABLE 45 POSTERIOR CERVICAL SCREWS MARKET, BY REGION, 2021–2028 (USD MILLION) 110
6.3.4.3 Posterior cervical rods 110
6.3.4.3.1 Advantages of newer screw-rod constructs to drive adoption 110
TABLE 46 POSTERIOR CERVICAL RODS MARKET, BY REGION, 2021–2028 (USD MILLION) 110
6.4 SPINE BIOLOGICS 110
TABLE 47 SPINE BIOLOGICS MARKET, BY TYPE, 2021–2028 (USD MILLION) 111
TABLE 48 SPINE BIOLOGICS MARKET, BY REGION, 2021–2028 (USD MILLION) 112
6.4.1 SPINE BIOLOGICS MARKET, BY APPLICATION 112
TABLE 49 SPINE BIOLOGICS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 112
6.4.2 SPINE BIOLOGICS MARKET, BY TYPE OF SURGERY 112
TABLE 50 SPINE BIOLOGICS MARKET, BY TYPE OF SURGERY, 2021–2028 (USD MILLION) 112
6.4.3 DEMINERALIZED BONE MATRIX 113
6.4.3.1 DBM to hold largest share of spine biologics market 113
TABLE 51 DEMINERALIZED BONE MATRIX MARKET, BY REGION, 2021–2028 (USD MILLION) 113
6.4.4 BONE MORPHOGENETIC PROTEINS 113
6.4.4.1 Safety and effectiveness to drive adoption 113
TABLE 52 BONE MORPHOGENETIC PROTEINS MARKET, BY REGION, 2021–2028 (USD MILLION) 114
6.4.5 BONE SUBSTITUTES 114
6.4.5.1 Easy availability, low cost, and other advantages to support adoption 114
TABLE 53 BONE SUBSTITUTES MARKET, BY REGION, 2021–2028 (USD MILLION) 115
6.4.6 MACHINED BONES 115
6.4.6.1 Rising popularity of PEEK and titanium spaces to restrain usage 115
TABLE 54 MACHINED BONES MARKET, BY REGION, 2021–2028 (USD MILLION) 115
6.4.7 CELL-BASED MATRICES 116
6.4.7.1 Complications such as risk of infection and sensory loss to affect demand 116
TABLE 55 CELL-BASED MATRICES MARKET, BY REGION, 2021–2028 (USD MILLION) 116
6.4.8 ALLOGRAFT BONE 116
6.4.8.1 Lower chance of successful fusion to limit adoption 116
TABLE 56 ALLOGRAFT BONE MARKET, BY REGION, 2021–2028 (USD MILLION) 117
6.5 VCF TREATMENT DEVICES 117
TABLE 57 VCF TREATMENT DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 117
TABLE 58 VCF TREATMENT DEVICES MARKET, BY REGION, 2021–2028 (USD MILLION) 118
6.5.1 VCF TREATMENT DEVICES MARKET, BY APPLICATION 118
TABLE 59 VCF TREATMENT DEVICES MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 118
6.5.2 VCF TREATMENT DEVICES MARKET, BY TYPE OF SURGERY 118
TABLE 60 VCF TREATMENT DEVICES MARKET, BY TYPE OF SURGERY, 2021–2028 (USD MILLION) 118
6.5.3 BALLOON KYPHOPLASTY DEVICES 119
6.5.3.1 Better surgical outcomes to ensure sustained demand 119
TABLE 61 BALLOON KYPHOPLASTY DEVICES MARKET, BY REGION, 2021–2028 (USD MILLION) 119
6.5.4 VERTEBROPLASTY DEVICES 119
6.5.4.1 Chances of cement leakage to limit adoption 119
TABLE 62 VERTEBROPLASTY DEVICES MARKET, BY REGION, 2021–2028 (USD MILLION) 120
6.6 SPINAL DECOMPRESSION DEVICES 120
TABLE 63 SPINAL DECOMPRESSION DEVICES MARKET, BY PROCEDURE, 2021–2028 (USD MILLION) 121
TABLE 64 SPINAL DECOMPRESSION DEVICES MARKET, BY REGION, 2021–2028 (USD MILLION) 121
6.6.1 SPINAL DECOMPRESSION DEVICES MARKET, BY APPLICATION 122
TABLE 65 SPINAL DECOMPRESSION DEVICES MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 122
6.6.2 SPINAL DECOMPRESSION DEVICES MARKET, BY TYPE OF SURGERY 122
TABLE 66 SPINAL DECOMPRESSION DEVICES MARKET, BY TYPE OF SURGERY, 2021–2028 (USD MILLION) 122
6.6.3 DISCECTOMY 122
6.6.3.1 Rising interest in microdiscectomy to support market growth 122
TABLE 67 SPINAL DECOMPRESSION DEVICES MARKET FOR DISCECTOMY, BY REGION, 2021–2028 (USD MILLION) 123
6.6.4 LAMINOPLASTY, LAMINECTOMY, AND LAMINOTOMY 123
6.6.4.1 Rising incidence of spinal stenosis to drive market 123
TABLE 68 SPINAL DECOMPRESSION DEVICES MARKET FOR LAMINOPLASTY, LAMINECTOMY, AND LAMINOTOMY, BY REGION, 2021–2028 (USD MILLION) 124
6.6.5 FORAMINOTOMY & FORAMINECTOMY 124
6.6.5.1 Growing preference for MIS treatment of cervical radiculopathy to support adoption 124
TABLE 69 SPINAL DECOMPRESSION DEVICES MARKET FOR FORAMINOTOMY & FORAMINECTOMY, BY REGION, 2021–2028 (USD MILLION) 125
6.6.6 FACETECTOMY 125
6.6.6.1 Rising awareness of MIS and risks of facetectomy to restrain growth 125
TABLE 70 SPINAL DECOMPRESSION DEVICES MARKET FOR FACETECTOMY, BY REGION, 2021–2028 (USD MILLION) 126
6.6.7 CORPECTOMY 126
6.6.7.1 Challenging procedures and inherent risks to affect demand 126
TABLE 71 SPINAL DECOMPRESSION DEVICES MARKET FOR CORPECTOMY, BY REGION, 2021–2028 (USD MILLION) 127
6.7 NON-FUSION DEVICES 127
TABLE 72 NON-FUSION DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 127
TABLE 73 NON-FUSION DEVICES MARKET, BY REGION, 2021–2028 (USD MILLION) 128
6.7.1 NON-FUSION DEVICES MARKET, BY APPLICATION 128
TABLE 74 NON-FUSION DEVICES MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 128
6.7.2 NON-FUSION DEVICES MARKET, BY TYPE OF SURGERY 128
TABLE 75 NON-FUSION DEVICES MARKET, BY TYPE OF SURGERY, 2021–2028 (USD MILLION) 128
6.7.3 DYNAMIC STABILIZATION DEVICES 129
TABLE 76 DYNAMIC STABILIZATION DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 129
TABLE 77 DYNAMIC STABILIZATION DEVICES MARKET, BY REGION, 2021–2028 (USD MILLION) 129
6.7.3.1 Interspinous process spacers 129
6.7.3.1.1 Positive outcomes and outpatient procedures to drive demand 129
TABLE 78 INTERSPINOUS PROCESS SPACERS MARKET, BY REGION, 2021–2028 (USD MILLION) 130
6.7.3.2 Pedicle screw-based dynamic rod devices 130
6.7.3.2.1 Need for long-term safety and efficacy evidence to restrain adoption 130
TABLE 79 PEDICLE SCREW-BASED DYNAMIC ROD DEVICES, BY REGION, 2021–2028 (USD MILLION) 130
6.7.3.3 Facet replacement products 131
6.7.3.3.1 Positive clinical outcomes and rising interest from players to support growth 131
TABLE 80 FACET REPLACEMENT PRODUCTS MARKET, BY REGION, 2021–2028 (USD MILLION) 131
6.7.4 ARTIFICIAL DISCS 131
TABLE 81 ARTIFICIAL DISCS MARKET, BY TYPE, 2021–2028 (USD MILLION) 131
TABLE 82 ARTIFICIAL DISCS MARKET, BY REGION, 2021–2028 (USD MILLION) 132
6.7.4.1 Artificial cervical discs 132
6.7.4.1.1 Increasing adoption of artificial disc replacement to drive market 132
TABLE 83 ARTIFICIAL CERVICAL DISCS MARKET, BY REGION, 2021–2028 (USD MILLION) 132
6.7.4.2 Artificial lumbar discs 133
6.7.4.2.1 Limited evidence for effectiveness and possibility of complications to hinder growth 133
TABLE 84 ARTIFICIAL LUMBAR DISCS MARKET, BY REGION, 2021–2028 (USD MILLION) 133
6.7.5 ANNULUS REPAIR DEVICES 134
6.7.5.1 Rising target patient population to drive usage 134
TABLE 85 ANNULUS REPAIR DEVICES MARKET, BY REGION, 2021–2028 (USD MILLION) 134
6.7.6 NUCLEAR DISC PROSTHESES 134
6.7.6.1 Nuclear disc prostheses to register high growth 134
TABLE 86 NUCLEAR DISC PROSTHESES MARKET, BY REGION, 2021–2028 (USD MILLION) 134
6.8 SPINE BONE STIMULATORS 135
TABLE 87 SPINE BONE STIMULATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 135
TABLE 88 SPINE BONE STIMULATORS MARKET, BY REGION, 2021–2028 (USD MILLION) 135
6.8.1 SPINE BONE STIMULATORS MARKET, BY APPLICATION 136
TABLE 89 SPINE BONE STIMULATORS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 136
6.8.2 SPINE BONE STIMULATORS MARKET, BY TYPE OF SURGERY 136
TABLE 90 SPINE BONE STIMULATORS MARKET, BY TYPE OF SURGERY, 2021–2028 (USD MILLION) 136
6.8.3 NONINVASIVE SPINE BONE STIMULATORS 136
TABLE 91 NONINVASIVE SPINE BONE STIMULATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 136
TABLE 92 NONINVASIVE SPINE BONE STIMULATORS MARKET, BY REGION, 2021–2028 (USD MILLION) 137
6.8.3.1 Pulsed electromagnetic field devices 137
6.8.3.2 CC & CMF devices 137
6.8.4 INVASIVE SPINE BONE STIMULATORS 138
6.8.4.1 Disadvantages and complications to affect pace of market growth 138
TABLE 93 INVASIVE SPINE BONE STIMULATORS MARKET, BY REGION, 2021–2028 (USD MILLION) 138
7 SPINAL IMPLANTS MARKET, BY TYPE OF SURGERY 139
7.1 INTRODUCTION 140
TABLE 94 SPINAL IMPLANTS MARKET, BY TYPE OF SURGERY, 2021–2028 (USD MILLION) 140
7.2 OPEN SURGERY 140
7.2.1 INCREASING PREFERENCE FOR OPEN SPINE SURGERIES TO DRIVE MARKET 140
TABLE 95 SPINAL IMPLANTS MARKET FOR OPEN SURGERY, BY REGION, 2021–2028 (USD MILLION) 141
7.3 MINIMALLY INVASIVE SURGERY 141
7.3.1 MINIMALLY INVASIVE SURGERY SEGMENT TO REGISTER HIGHEST GROWTH 141
TABLE 96 SPINAL IMPLANTS MARKET FOR MINIMALLY INVASIVE SURGERY, BY REGION, 2021–2028 (USD MILLION) 142
8 SPINAL IMPLANTS MARKET, BY APPLICATION 143
8.1 INTRODUCTION 144
TABLE 97 SPINAL IMPLANTS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 144
8.2 SPINAL FUSION & FIXATION 144
8.2.1 SPINAL FUSION & FIXATION TECHNOLOGIES TO DOMINATE MARKET OVER FORECAST PERIOD 144
TABLE 98 SPINAL IMPLANTS MARKET FOR SPINAL FUSION & FIXATION, BY REGION, 2021–2028 (USD MILLION) 145
8.3 VCF TREATMENT 145
8.3.1 INCREASING FRACTURE INCIDENCE TO SUPPORT MARKET GROWTH 145
TABLE 99 SPINAL IMPLANTS MARKET FOR VCF TREATMENT, BY REGION, 2021–2028 (USD MILLION) 146
8.4 MOTION PRESERVATION/NON-FUSION 146
8.4.1 MOTION PRESERVATION/NON-FUSION TECHNOLOGIES TO WITNESS HIGHEST GROWTH 146
TABLE 100 SPINAL IMPLANTS MARKET FOR MOTION PRESERVATION/NON-FUSION, BY REGION, 2021–2028 (USD MILLION) 147
8.5 SPINAL DECOMPRESSION 147
8.5.1 RISING INCIDENCE OF SPINAL TUMORS AND DEVELOPMENT OF MINIMALLY INVASIVE DEVICES TO DRIVE MARKET 147
TABLE 101 SPINAL IMPLANTS MARKET FOR SPINAL DECOMPRESSION, BY REGION, 2021–2028 (USD MILLION) 148
9 SPINAL IMPLANTS MARKET, BY END USER 149
9.1 INTRODUCTION 150
TABLE 102 SPINAL IMPLANTS MARKET, BY END USER, 2021–2028 (USD MILLION) 150
9.2 HOSPITALS 150
9.2.1 HOSPITALS TO HOLD LARGEST MARKET SHARE 150
TABLE 103 SPINAL IMPLANTS MARKET FOR HOSPITALS, BY REGION, 2021–2028 (USD MILLION) 150
9.3 ORTHOPEDIC CENTERS 151
9.3.1 EARLY DETECTION OF SPINAL DISORDERS AND LOWER TURNAROUND TIME TO DRIVE MARKET 151
TABLE 104 SPINAL IMPLANTS MARKET FOR ORTHOPEDIC CENTERS, BY REGION, 2021–2028 (USD MILLION) 151
10 SPINAL IMPLANTS MARKET, BY REGION 152
10.1 INTRODUCTION 153
TABLE 105 SPINAL IMPLANTS MARKET, BY REGION, 2021–2028 (USD MILLION) 153
10.2 NORTH AMERICA 153
10.2.1 NORTH AMERICA: RECESSION IMPACT 153
FIGURE 25 NORTH AMERICA: MARKET SNAPSHOT 154
TABLE 106 NORTH AMERICA: SPINAL IMPLANTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 154
TABLE 107 NORTH AMERICA: SPINAL IMPLANTS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 155
TABLE 108 NORTH AMERICA: THORACIC & LUMBAR FUSION DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 155
TABLE 109 NORTH AMERICA: INTERBODY THORACIC & LUMBAR FUSION DEVICES MARKET, BY APPROACH, 2021–2028 (USD MILLION) 156
TABLE 110 NORTH AMERICA: INTERBODY THORACIC & LUMBAR FUSION DEVICES MARKET, BY MATERIAL, 2021–2028 (USD MILLION) 156
TABLE 111 NORTH AMERICA: CERVICAL FUSION DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 157
TABLE 112 NORTH AMERICA: ANTERIOR CERVICAL FUSION DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 157
TABLE 113 NORTH AMERICA: POSTERIOR CERVICAL FUSION DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 157
TABLE 114 NORTH AMERICA: SPINE BIOLOGICS MARKET, BY TYPE, 2021–2028 (USD MILLION) 158
TABLE 115 NORTH AMERICA: VCF TREATMENT DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 158
TABLE 116 NORTH AMERICA: SPINAL DECOMPRESSION DEVICES MARKET, BY PROCEDURE, 2021–2028 (USD MILLION) 159
TABLE 117 NORTH AMERICA: NON-FUSION DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 159
TABLE 118 NORTH AMERICA: DYNAMIC STABILIZATION DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 160
TABLE 119 NORTH AMERICA: ARTIFICIAL DISCS MARKET, BY TYPE, 2021–2028 (USD MILLION) 160
TABLE 120 NORTH AMERICA: SPINE BONE STIMULATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 160
TABLE 121 NORTH AMERICA: NONINVASIVE SPINE BONE STIMULATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 161
TABLE 122 NORTH AMERICA: SPINAL IMPLANTS MARKET, BY TYPE OF SURGERY, 2021–2028 (USD MILLION) 161
TABLE 123 NORTH AMERICA: SPINAL IMPLANTS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 161
TABLE 124 NORTH AMERICA: SPINAL IMPLANTS MARKET, BY END USER, 2021–2028 (USD MILLION) 162
10.2.2 US 162
10.2.2.1 US to dominate North American market 162
TABLE 125 US: SPINAL IMPLANTS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 162
TABLE 126 US: THORACIC & LUMBAR FUSION DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 163
TABLE 127 US: CERVICAL FUSION DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 163
TABLE 128 US: SPINE BIOLOGICS MARKET, BY TYPE, 2021–2028 (USD MILLION) 164
TABLE 129 US: VCF TREATMENT DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 164
TABLE 130 US: SPINAL DECOMPRESSION DEVICES MARKET, BY PROCEDURE, 2021–2028 (USD MILLION) 165
TABLE 131 US: NON-FUSION DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 165
TABLE 132 US: SPINE BONE STIMULATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 165
10.2.3 CANADA 166
10.2.3.1 Inadequate reimbursement for spinal procedures to restrain market growth 166
TABLE 133 CANADA: SPINAL IMPLANTS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 166
TABLE 134 CANADA: THORACIC & LUMBAR FUSION DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 167
TABLE 135 CANADA: CERVICAL FUSION DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 167
TABLE 136 CANADA: SPINE BIOLOGICS MARKET, BY TYPE, 2021–2028 (USD MILLION) 168
TABLE 137 CANADA: VCF TREATMENT DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 168
TABLE 138 CANADA: SPINAL DECOMPRESSION DEVICES MARKET, BY PROCEDURE, 2021–2028 (USD MILLION) 169
TABLE 139 CANADA: NON-FUSION DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 169
TABLE 140 CANADA: SPINE BONE STIMULATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 169
10.3 EUROPE 170
10.3.1 EUROPE: RECESSION IMPACT 170
TABLE 141 EUROPE: SPINAL IMPLANTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 170
TABLE 142 EUROPE: SPINAL IMPLANTS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 171
TABLE 143 EUROPE: THORACIC & LUMBAR FUSION DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 171
TABLE 144 EUROPE: INTERBODY THORACIC & LUMBAR FUSION DEVICES MARKET, BY APPROACH, 2021–2028 (USD MILLION) 172
TABLE 145 EUROPE: INTERBODY THORACIC & LUMBAR FUSION DEVICES MARKET, BY MATERIAL, 2021–2028 (USD MILLION) 172
TABLE 146 EUROPE: CERVICAL FUSION DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 173
TABLE 147 EUROPE: ANTERIOR CERVICAL FUSION DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 173
TABLE 148 EUROPE: POSTERIOR CERVICAL FUSION DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 173
TABLE 149 EUROPE: SPINE BIOLOGICS MARKET, BY TYPE, 2021–2028 (USD MILLION) 174
TABLE 150 EUROPE: VCF TREATMENT DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 174
TABLE 151 EUROPE: SPINAL DECOMPRESSION DEVICES MARKET, BY PROCEDURE, 2021–2028 (USD MILLION) 175
TABLE 152 EUROPE: NON-FUSION DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 175
TABLE 153 EUROPE: DYNAMIC STABILIZATION DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 176
TABLE 154 EUROPE: ARTIFICIAL DISCS MARKET, BY TYPE, 2021–2028 (USD MILLION) 176
TABLE 155 EUROPE: SPINE BONE STIMULATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 176
TABLE 156 EUROPE: NONINVASIVE SPINE BONE STIMULATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 177
TABLE 157 EUROPE: SPINAL IMPLANTS MARKET, BY TYPE OF SURGERY, 2021–2028 (USD MILLION) 177
TABLE 158 EUROPE: SPINAL IMPLANTS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 177
TABLE 159 EUROPE: SPINAL IMPLANTS MARKET, BY END USER, 2021–2028 (USD MILLION) 178
10.3.2 GERMANY 178
10.3.2.1 Germany to hold largest market share in Europe 178
TABLE 160 GERMANY: SPINAL IMPLANTS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 178
TABLE 161 GERMANY: THORACIC & LUMBAR FUSION DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 179
TABLE 162 GERMANY: CERVICAL FUSION DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 179
TABLE 163 GERMANY: SPINE BIOLOGICS MARKET, BY TYPE, 2021–2028 (USD MILLION) 180
TABLE 164 GERMANY: VCF TREATMENT DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 180
TABLE 165 GERMANY: SPINAL DECOMPRESSION DEVICES MARKET, BY PROCEDURE, 2021–2028 (USD MILLION) 181
TABLE 166 GERMANY: NON-FUSION DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 181
TABLE 167 GERMANY: SPINE BONE STIMULATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 181
10.3.3 FRANCE 182
10.3.3.1 Rising healthcare expenditure to support market growth 182
TABLE 168 FRANCE: SPINAL IMPLANTS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 182
TABLE 169 FRANCE: THORACIC & LUMBAR FUSION DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 182
TABLE 170 FRANCE: CERVICAL FUSION DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 183
TABLE 171 FRANCE: SPINE BIOLOGICS MARKET, BY TYPE, 2021–2028 (USD MILLION) 183
TABLE 172 FRANCE: VCF TREATMENT DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 183
TABLE 173 FRANCE: SPINAL DECOMPRESSION DEVICES MARKET, BY PROCEDURE, 2021–2028 (USD MILLION) 184
TABLE 174 FRANCE: NON-FUSION DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 184
TABLE 175 FRANCE: SPINE BONE STIMULATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 184
10.3.4 UK 185
10.3.4.1 Rising cost of spinal surgeries to hinder market growth 185
TABLE 176 UK: SPINAL IMPLANTS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 185
TABLE 177 UK: THORACIC & LUMBAR FUSION DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 186
TABLE 178 UK: CERVICAL FUSION DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 186
TABLE 179 UK: SPINE BIOLOGICS MARKET, BY TYPE, 2021–2028 (USD MILLION) 187
TABLE 180 UK: VCF TREATMENT DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 187
TABLE 181 UK: SPINAL DECOMPRESSION DEVICES MARKET, BY PROCEDURE, 2021–2028 (USD MILLION) 188
TABLE 182 UK: NON-FUSION DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 188
TABLE 183 UK: SPINE BONE STIMULATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 188
10.3.5 ITALY 189
10.3.5.1 Demand for MIS to positively affect market growth 189
TABLE 184 ITALY: SPINAL IMPLANTS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 189
TABLE 185 ITALY: THORACIC & LUMBAR FUSION DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 190
TABLE 186 ITALY: CERVICAL FUSION DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 190
TABLE 187 ITALY: SPINE BIOLOGICS MARKET, BY TYPE, 2021–2028 (USD MILLION) 191
TABLE 188 ITALY: VCF TREATMENT DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 191
TABLE 189 ITALY: SPINAL DECOMPRESSION DEVICES MARKET, BY PROCEDURE, 2021–2028 (USD MILLION) 192
TABLE 190 ITALY: NON-FUSION DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 192
TABLE 191 ITALY: SPINE BONE STIMULATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 192
10.3.6 SPAIN 193
10.3.6.1 Growing preference for MIS to support market growth 193
TABLE 192 SPAIN: SPINAL IMPLANTS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 193
TABLE 193 SPAIN: THORACIC & LUMBAR FUSION DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 194
TABLE 194 SPAIN: CERVICAL FUSION DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 194
TABLE 195 SPAIN: SPINE BIOLOGICS MARKET, BY TYPE, 2021–2028 (USD MILLION) 195
TABLE 196 SPAIN: VCF TREATMENT DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 195
TABLE 197 SPAIN: SPINAL DECOMPRESSION DEVICES MARKET, BY PROCEDURE, 2021–2028 (USD MILLION) 196
TABLE 198 SPAIN: NON-FUSION DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 196
TABLE 199 SPAIN: SPINE BONE STIMULATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 196
10.3.7 REST OF EUROPE 197
TABLE 200 REST OF EUROPE: SPINAL IMPLANTS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 197
TABLE 201 REST OF EUROPE: THORACIC & LUMBAR FUSION DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 197
TABLE 202 REST OF EUROPE: CERVICAL FUSION DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 198
TABLE 203 V: SPINE BIOLOGICS MARKET, BY TYPE, 2021–2028 (USD MILLION) 198
TABLE 204 REST OF EUROPE: VCF TREATMENT DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 198
TABLE 205 REST OF EUROPE: SPINAL DECOMPRESSION DEVICES MARKET, BY PROCEDURE, 2021–2028 (USD MILLION) 199
TABLE 206 REST OF EUROPE: NON-FUSION DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 199
TABLE 207 REST OF EUROPE: SPINE BONE STIMULATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 199